<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Limites et faiblesses du traitement intermittent dans la pr&#xE9;vention du paludisme</dc:title>
  <dc:creator>/Chippaux, Jean-Philippe</dc:creator>
  <dc:creator>/Le Hesran, Jean-Yves</dc:creator>
  <dc:creator>/Cot, Michel</dc:creator>
  <dc:creator>Massougbodji, A.</dc:creator>
  <dc:subject>PALUDISME</dc:subject>
  <dc:subject>TRAITEMENT MEDICAL</dc:subject>
  <dc:subject>ENFANT D'AGE PRESCOLAIRE</dc:subject>
  <dc:subject>VACCINATION</dc:subject>
  <dc:subject>CHIMIOPROPHYLAXIE</dc:subject>
  <dc:subject>SENSIBILITE RESISTANCE</dc:subject>
  <dc:subject>SULFADOXINE PYRIMETHAMINE</dc:subject>
  <dc:subject>CHLOROQUINE</dc:subject>
  <dc:subject>TRAITEMENT INTERMITTENT</dc:subject>
  <dc:date>2003</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010031351</dc:identifier>
  <dc:identifier>fdi:010031351</dc:identifier>
  <dc:identifier>Chippaux Jean-Philippe, Le Hesran Jean-Yves, Cot Michel, Massougbodji A.. Limites et faiblesses du traitement intermittent dans la pr&#xE9;vention du paludisme. 2003, 96 (2),  75-76</dc:identifier>
  <dc:language>FR</dc:language>
  <dc:coverage>TANZANIE</dc:coverage>
</oai_dc:dc>
